week in cancer news

A researcher with melanoma writes about his experiences trying to modify his gut microbiome, and an article discusses what it means to call a cancer treatment “well tolerated.”

by Kate Yandell

More than half of patients with advanced melanoma who took an immunotherapy combination were alive five years later, and a targeted therapy appears to cause high blood pressure.

by Kate Yandell

A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.

by Bradley Jones

Article describes efforts to support cancer survivors, radiation meeting focuses on treatment de-escalation, and studies show that brain tumor cells have their own neural network.

by Marci A. Landsmann

Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.

by Kate Yandell

Organizations release guidelines on reducing breast cancer risk using medications, and a palliative care doctor discusses the pros and cons of dying at home.

by Kate Yandell

A study looks at hormone therapy and breast cancer risk, and researchers take a closer look at marijuana use in young cancer patients.

by Marci A. Landsmann

Recommendations say that a broader group of women should be considered for BRCA mutation testing, and the U.S. Food and Drug Administration issues a proposal to require that cigarettes come with graphic warnings.

by Kate Yandell

A radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.

by Kate Yandell

A liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.

by Kevin McLaughlin